These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 20300967
1. Ratio of metastatic to resected lymph nodes as a prognostic factor in node-positive colorectal cancer. Huh JW, Kim YJ, Kim HR. Ann Surg Oncol; 2010 Oct; 17(10):2640-6. PubMed ID: 20300967 [Abstract] [Full Text] [Related]
2. Ratio of metastatic to resected lymph nodes enhances to predict survival in patients with stage III colorectal cancer. Qiu HB, Zhang LY, Li YF, Zhou ZW, Keshari RP, Xu RH. Ann Surg Oncol; 2011 Jun; 18(6):1568-74. PubMed ID: 21207155 [Abstract] [Full Text] [Related]
3. Prognostic value of lymph node ratio in stage III colorectal cancer. Wong KP, Poon JT, Fan JK, Law WL. Colorectal Dis; 2011 Oct; 13(10):1116-22. PubMed ID: 20874800 [Abstract] [Full Text] [Related]
4. The prognostic value of lymph node ratio in a population-based collective of colorectal cancer patients. Rosenberg R, Engel J, Bruns C, Heitland W, Hermes N, Jauch KW, Kopp R, Pütterich E, Ruppert R, Schuster T, Friess H, Hölzel D. Ann Surg; 2010 Jun; 251(6):1070-8. PubMed ID: 20485149 [Abstract] [Full Text] [Related]
5. Prognostic significance of the metastatic lymph node ratio in node-positive rectal cancer. Peng J, Xu Y, Guan Z, Zhu J, Wang M, Cai G, Sheng W, Cai S. Ann Surg Oncol; 2008 Nov; 15(11):3118-23. PubMed ID: 18769971 [Abstract] [Full Text] [Related]
6. Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons. Vaccaro CA, Im V, Rossi GL, Quintana GO, Benati ML, Perez de Arenaza D, Bonadeo FA. Dis Colon Rectum; 2009 Jul; 52(7):1244-50. PubMed ID: 19571700 [Abstract] [Full Text] [Related]
7. Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma. Falconi M, Crippa S, Domínguez I, Barugola G, Capelli P, Marcucci S, Beghelli S, Scarpa A, Bassi C, Pederzoli P. Ann Surg Oncol; 2008 Nov; 15(11):3178-86. PubMed ID: 18712568 [Abstract] [Full Text] [Related]
8. Metastatic lymph node ratio as a prognostic factor in gastric cancer. Rodríguez Santiago JM, Muñoz E, Martí M, Quintana S, Veloso E, Marco C. Eur J Surg Oncol; 2005 Feb; 31(1):59-66. PubMed ID: 15642427 [Abstract] [Full Text] [Related]
9. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined. Cianchi F, Palomba A, Boddi V, Messerini L, Pucciani F, Perigli G, Bechi P, Cortesini C. World J Surg; 2002 Mar; 26(3):384-9. PubMed ID: 11865379 [Abstract] [Full Text] [Related]
10. The number of analyzed lymph nodes - a prognostic factor in colorectal cancer. Edler D, Ohrling K, Hallström M, Karlberg M, Ragnhammar P. Acta Oncol; 2007 Mar; 46(7):975-81. PubMed ID: 17917828 [Abstract] [Full Text] [Related]
11. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study. Mukai M, Ito I, Mukoyama S, Tajima T, Saito Y, Nakasaki H, Sato S, Makuuchi H. Oncol Rep; 2003 Mar; 10(4):927-34. PubMed ID: 12792747 [Abstract] [Full Text] [Related]
12. Can lymph node ratio take the place of pN categories in the UICC/AJCC TNM classification system for colorectal cancer? Tong LL, Gao P, Wang ZN, Song YX, Xu YY, Sun Z, Xing CZ, Wang X, Xu HM. Ann Surg Oncol; 2011 Sep; 18(9):2453-60. PubMed ID: 21455596 [Abstract] [Full Text] [Related]
13. The impact of the ratio of positive to total lymph nodes examined and outcome in colorectal cancer. Ng M, Roy-Chowdhury S, Lum SS, Morgan JW, Wong JH. Am Surg; 2009 Oct; 75(10):873-6. PubMed ID: 19886125 [Abstract] [Full Text] [Related]
14. [Multivariate regression analysis of recurrence following curative surgery for colorectal cancer]. Liang JL, Wan DS, Pan ZZ, Zhou ZW, Chen G, Li LR, Lu ZH, Wu XJ. Ai Zheng; 2004 May; 23(5):564-7. PubMed ID: 15142455 [Abstract] [Full Text] [Related]
15. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor. Deng Y, Kurland BF, Wang J, Bi J, Li W, Rao S, Lan P, Lin T, Lin E. Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802 [Abstract] [Full Text] [Related]
16. Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period. Rosenberg R, Friederichs J, Schuster T, Gertler R, Maak M, Becker K, Grebner A, Ulm K, Höfler H, Nekarda H, Siewert JR. Ann Surg; 2008 Dec; 248(6):968-78. PubMed ID: 19092341 [Abstract] [Full Text] [Related]
17. Regional Lymph Nodes Status and Ratio of Metastatic to Examined Lymph Nodes Correlate with Survival in Stage IV Colorectal Cancer. Ahmed S, Leis A, Chandra-Kanthan S, Fields A, Zaidi A, Abbas T, Le D, Reeder B, Pahwa P. Ann Surg Oncol; 2016 Jul; 23(7):2287-94. PubMed ID: 27016291 [Abstract] [Full Text] [Related]
18. Immunohistochemical assessment of localization and frequency of micrometastases in lymph nodes of colorectal cancer. Noura S, Yamamoto H, Miyake Y, Kim Bn, Takayama O, Seshimo I, Ikenaga M, Ikeda M, Sekimoto M, Matsuura N, Monden M. Clin Cancer Res; 2002 Mar; 8(3):759-67. PubMed ID: 11895906 [Abstract] [Full Text] [Related]
19. Isolated tumor cells in lymph nodes are not a prognostic marker for patients with stage I and stage II colorectal cancer. Lee MR, Hong CW, Yoon SN, Lim SB, Park KJ, Lee MJ, Kim WH, Park JG. J Surg Oncol; 2006 Jan 01; 93(1):13-8; discussion 18-9. PubMed ID: 16353185 [Abstract] [Full Text] [Related]
20. Metastatic potential in T1 and T2 colorectal cancer. Fang WL, Chang SC, Lin JK, Wang HS, Yang SH, Jiang JK, Chen WC, Lin TC. Hepatogastroenterology; 2005 Jan 01; 52(66):1688-91. PubMed ID: 16334758 [Abstract] [Full Text] [Related] Page: [Next] [New Search]